Risk of serious adverse events after the BNT162b2, CoronaVac, and ChAdOx1 vaccines in Malaysia: A self-controlled case series studyNorazida Ab Rahman, Kalaiarasu M. Peariasamy, Raj Kumar Sevalingam et al.|Vaccine|2022Cited by 41
Myocarditis/pericarditis following vaccination with BNT162b2, CoronaVac, and ChAdOx1 among adolescent and adult in MalaysiaNorazida Ab Rahman, Sheamini Sivasampu, Ming Tsuey Lim et al.|Vaccine X|2023Cited by 6
Thrombocytopenia and venous thromboembolic events after BNT162b2, CoronaVac, ChAdOx1 vaccines and SARS-CoV-2 infection: a self-controlled case series studyNorazida Ab Rahman, Nor Azizah Mohamad Nazri, Ming Tsuey Lim et al.|Scientific Reports|2023Cited by 6
A Case-Based Monitoring Approach to Evaluate Safety of COVID-19 Vaccines in a Partially Integrated Health Information System: A Study ProtocolNorazida Ab Rahman, Sheamini Sivasampu, Su Miin Ong et al.|Frontiers in Pharmacology|2022Cited by 3